Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 397-404

  Fu, Weiling ^a,b   Forster, Terri ^a   Mayer, Oren ^a   Curtin, John J ^a   Lehman, Susan M ^a   Donlan, Rodney M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOFILM; CATHETER; CELL DENSITY; CELL LYSATE; COLONY FORMING UNIT; CONTROLLED STUDY; HYDROGEL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE;

BACTERIOPHAGES; BIOFILMS; CATHETERIZATION; COLONY COUNT, MICROBIAL; CULTURE MEDIA; MICROSCOPY, ELECTRON, SCANNING; PSEUDOMONAS AERUGINOSA;

EID: 73849146761     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00669-09     Document Type: Article

References (45)

1. Ackermann, H.-W., C. Cartier, S. Slopek, and J.-F. Vieu. 1988. Morphology of Pseudomonas aeruginosa typing phages of the Lindberg set. Ann. Inst. Pasteur Virol. 139:389-404.
2. Adams, M. 1959. Bacteriophages. Interscience Publishers, London, United Kingdom.
3. Ahearn, D. G., D. T. Grace, M. J. Jennings, R. N. Borazjani, K. J. Boles, L. J. Rose, R. B. Simmons, and E. N. Ahanotu. 2000. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr. Microbiol. 41:120-125.
4. Allison, G. E., and T. R. Klaenhammer. 1998. Phage resistance mechanisms in lactic acid bacteria. Int. Dairy J. 8:207-226.
5. Barrangou, R., C. Fremaux, H. Deveau, M. Richards, P. Boyaval, S. Moineau, D. A. Romero, and P. Horvath. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712.
6. Barrow, P., M. Lovell, and A. Berchieri, Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin. Diagn. Lab. Immunol. 5:294-298.
7. Blondel-Hill, E., D. A. Henry, and D. P. Speert. 2007. Pseudomonas, p. 734-748. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed., vol. 1. ASM Press, Washington, DC.
8. Carlson, K. 2005. Appendix: working with bacteriophages: common techniques and methodological approaches, p. 437-494. In E. Kutter and A. Sulakvelidze (ed.), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.
9. Centers for Disease Control and Prevention. 2002. Guidelines for prevention of intravascular catheter-related infections. MMWR 51(RR-10):1-32.
10. Cerca, N., R. Oliveira, and J. Azeredo. 2007. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett. Appl. Microbiol. 45:313-317.
11. Christensen, G. D., W. A. Simpson, J. J. Younger, L. M. Baddour, F. F. Barrett, D. M. Melton, and E. H. Beachey. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006.
12. Corbin, B. D., R. J. C. McLean, and G. M. Aron. 2001. Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm. Can. J. Microbiol. 47:680-684.
13. Curtin, J. J., and R. M. Donlan. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50:1268-1275.
14. Deretic, V., M. J. Schurr, J. C. Boucher, and D. W. Martin. 1994. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176:2773-2780.
15. Déziel, E., Y. Comeau, and R. Villemur. 2001. Initiation and biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J. Bacteriol. 183:1195- 1204.
16. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
17. Donlan, R. M. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66-72.
18. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1995. Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can. J. Microbiol. 41:12-18.
19. Doolittle, M. M., J. J. Cooney, and D. E. Caldwell. 1996. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J. Indust. Microbiol. 16:331-341.
20. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
21. Fu, W., T. Forster, O. Mayer, J. J. Curtin, S. M. Lehman, and R. M. Donlan. 2007. Poster no. A-011. Abstr. Am. Soc. Microbiol. Gen. Meet., American Society for Microbiology, Washington, DC.
22. Guttman, B., R. Raya, and E. Kutter. 2005. Basic phage biology, p. 29-66. In E. Kutter and A. Sulakvelidze (ed.), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.
23. Hadas, H., M. Einav, I. Fishov, and A. Zaritsky. 1997. Bacteriophage T4 development depends on the physiology of its host Escherichia coli. Microbiology 143:179-185.
24. Hanlon, G. W., S. P. Denyer, C. J. Olliff, and L. J. Ibrahim. 2001. Reduction of exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 67:2746-2753.
25. Häussler, S., B. Tummler, H. Wessbrodt, M. Rohde, and I. Steinmetz. 1999. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29:621-625.
26. Hughes, K. A., I. W. Sutherland, and M. V. Jones. 1998. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144:3039-3047.
27. Jones, J. B., L. E. Jackson, B. Balogh, A. Obradovic, F. B. Iriarte, and M. T. Momol. 2007. Bacteriophages for plant disease control. Annu. Rev. Phytopathol. 45:245-262.
28. Karlson, K. 1994. Single-step growth, p. 434-436. In J. D. Karam, J. W. Drake, and K. N. Kreuzer (ed.), Molecular biology of bacteriophage T4. American Society for Microbiology, Washington, DC.
29. Lenski, R. E. 1988. Dynamics of interactions between bacteria and virulent bacteriophage, p. 1-44. In K. C. Marshall (ed.), Advances in microbial ecology. Plenum Press, New York, NY.
30. Lenski, R. E., and B. R. Levin. 1985. Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. Am. Nat. 125:585-602.
31. Lu, T. K., and J. J. Collins. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl. Acad. Sci. USA 104:11197-11202.
32. Markoishvili, K., G. Tsitlanadze, R. Katsarava, J. G. Morris, Jr., and A. Sulakvelidze. 2002. A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int. J. Dermatol. 41:453-458.
33. Mooij, M. J., E. Drenkard, M. A. Llamas, C. M. J. E. Vanderbroucke-Grauls, P. H. M. Savelkoul, F. M. Ausubel, and W. Bitter. 2007. Characterization of the integrated filamentous phage Pf5 and its involvement in small-colony formation. Microbiology 153:1790-1798.
34. O'Flaherty, S. R., R. P. Ross, W. Meaney, G. F. Fitzgerald, M. F. Elbreki, and A. Coffey. 2005. Potential of polyvalent anti- Staphylococcus bacteriophage K for control of antibiotic resistant staphylococci from hospitals. Appl. Environ. Microbiol. 71:1836-1842.
35. O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
36. Pitt, T. L. 1988. Epidemiologica typing of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 7:238-247.
37. Raad, I., R. Darouiche, R. Hachem, M. Sacilowski, and G. P. Bodey. 1995. Antibiotics and prevention of microbial colonization of catheters. Antimicrob. Agents Chemother. 39:2397-2400.
38. Rice, S. A., C. H. Tan, P. J. Mikkelsen, V. Kung, J. Woo, M. Tay, A. Hauser, D. McDonald, J. S. Webb, and S. Kjelleberg. 2009. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J. 3:271-282.
39. Sillankorva, S., R. Oliveira, M. J. Vieira, I. W. Sutherland, and J. Azeredo. 2004. Bacteriophage ΦS1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20:133-138.
40. Slopek, S., B. Weber-Dabrowska, M. Dabrowski, and A. Kucharewicz-Krukowska. 1987. Results of bacteriophage treatment of supparative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exper. 35:569-570.
41. Sulakvelidze, A., and E. Kutter. 2005. Bacteriophage therapy in humans, p. 381-436. In E. Kutter and A. Sulakvelidze (ed.), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.
42. Webb, J. S., M. Lau, and S. Kjelleberg. 2004. Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186:8066-8073.
43. Webb, J. S., L. S. Thompson, S. James, T. Charlton, T. Tolker-Nielsen, B. Koch, M. Givskov, and S. Kjelleberg. 2003. Cell death in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 185:4585-4592.
44. Weber-Dabrowska, B., M. Mulczyk, and A. Gorski. 2000. Bacteriophage therapy of bacterial infections: an update of our institution's experience. Arch. Immunol. Ther. Exp. 48:547-551.
45. Wenzel, R. P., and M. B. Edmond. 1999. The evolving technology of venous access. N. Engl. J. Med. 340:48-50.